Related Experiment Video
Updated: Apr 5, 2026

07:06
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
Published on: January 10, 2025
1.3K
Giant Platelets in Platelet Donors - A Blessing in Disguise?
Asitava Deb Roy1, Nabajyoti Choudhury2, Deepanjan Ray3
1Assistant Professor, Department of Pathology and In Charge Transfusion Medicine, IQ City Medical College , Durgapur, West Bengal, India .
Journal of Clinical and Diagnostic Research : JCDR
|August 13, 2015
Summary
Giant platelets are common in Eastern India. Screening platelet donors with peripheral smear examination can identify these individuals, preventing unnecessary rejection and ensuring effective platelet transfusions.
Area of Science:
- Hematology
- Transfusion Medicine
Background:
- Inherited giant platelet disorders (IGPD) are rare but likely underdiagnosed.
- Harris platelet syndrome, an IGPD common in the Indian subcontinent, presents with low platelet count, high mean platelet volume (MPV), and no bleeding.
Purpose of the Study:
- To determine the prevalence of giant platelets in single donor platelet (SDP) apheresis donors.
- To evaluate the impact of transfusing SDPs from donors with giant platelets into patients.
Main Methods:
- Screening of 45 voluntary SDP donors using complete blood count and peripheral smear.
- Platelet counts and yield were assessed post-apheresis.
- Transfusion of SDPs and monitoring of post-transfusion platelet recovery in patients.
Main Results:
- Giant platelets were found in 66.67% (30/45) of screened donors.
- Donors with giant platelets had lower pre-procedure platelet counts and platelet yield compared to others.
- Post-transfusion platelet recovery was higher in patients receiving SDPs from donors with giant platelets.
Conclusions:
- Giant platelets are prevalent in Eastern India.
- Peripheral smear examination is crucial for screening apheresis donors to avoid misinterpreting low platelet counts due to giant platelets.
- This screening can prevent donor rejection and optimize platelet transfusion efficacy.
Keywords:
Apheresis donorsRelated Concept Videos
Structure and Function of Platelets
5.4K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
5.4K
Formation of the Platelet Plug
10.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K

